Levobunolol Base from Japan
Levobunolol base, an aromatic amino-alcohol-phenol derivative structurally analogous to listed phenylephrine, used as beta-blocker intermediate for glaucoma treatment. Classified here under the specific enumerated compounds provision of HTS 2922.50.10.00.
Duty Rate — Japan → United States
21.7%
Rate breakdown
9903.04.629.2%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.4912.5%Except for products described in headings 9903.05.85–9903.05.92, articles the product of Japan, with an ad valorem (or ad valorem equivalent) rate of duty under column 1 less than 12.5 percent, as provided for in U.S. note 52 to this subchapter
Import Tips
• Include pharmacopeial compliance (USP/EP) certificates for purity >98%
• DEA monitoring for beta-blocker precursors; declare research/pharma use
• Chiral purity documentation if enantiopure form imported